SCHEMBL4461063

SCHEMBL4461063

Cc1cc(NC(=O)C(C)(C)NC(=O)c2ccc(Br)s2)ccc1N1CCOCC/C1=N/C#N

nearest known ligand 0.58

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
F10 P00742 14/20 0.58
AR P10275 3/20 0.46
HTT P42858 1/20 0.38
MITF O75030 1/20 0.37
PAX8 Q06710 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4468098 0.92 F10 (0.70) F10ARHTT
SCHEMBL13965131 0.92 F10 (0.70) F10ARHTT
SCHEMBL4462935 0.86 F10 (0.71) F10ARHTT
SCHEMBL4005062 0.82 F10 (0.83) F10AR
SCHEMBL4460893 0.82 F10 (0.39) F10HTTMITFPAX8
SCHEMBL13965134 0.82 F10 (0.39) F10HTTMITFPAX8
SCHEMBL13062211 0.82 F10 (0.39) F10HTTMITFPAX8
SCHEMBL4558084 0.82 F10 (0.39) F10HTTMITFPAX8
SCHEMBL13062292 0.82 F10 (0.39) F10HTTMITFPAX8
SCHEMBL4465502 0.82 F10 (0.69) F10AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476663-B2 Substituted thiophene carboxamides BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-01-13 US disclosed
US-20050277628-A1 Substituted thiophene carboxamides BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050277628-A1 Substituted thiophene carboxamides OTC, SLC22A8, DDC F10 2132/4885AR 2088/4885HTT 2031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.